A study reported Feb. 17 in the journal Science led by researchers at Indiana University and Harvard University is the first to reveal in extreme detail the operation of the biochemical clockwork that drives cellular division ...
Cell & Microbiology
Feb 16, 2017
0
14
Phage therapy, which exploits the ability of certain viruses to infect and replicate within bacteria, shows promise for treating antibiotic-resistant bacterial infections.
Cell & Microbiology
Jan 11, 2017
1
698
Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor. This new take on how the microbial context can compromise antibiotic therapy ...
Cell & Microbiology
Dec 27, 2016
0
3687
In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide ...
Ecology
Dec 5, 2016
0
904
A naturally occurring predatory bacterium is able to work with the immune system to clear multi-drug resistant Shigella infections in zebrafish, according to a study published today in Current Biology.
Cell & Microbiology
Nov 23, 2016
0
19
A new microscopic technique is enabling scientists to observe the antibiotic daptomycine live in action. This marks an exciting first, because even though doctors have been prescribing this antibiotic for over a decade, its ...
Cell & Microbiology
Oct 25, 2016
0
6
Scientists have discovered a bacteria 'alarm clock' that wakes dormant Salmonella in the body, allowing the bug to trigger a repeat infection.
Cell & Microbiology
Oct 19, 2016
1
33
In adhering to body cells, many bacteria cause disease. Antibiotics are the usual means for treating infection, but decades of use have led to increasing bacterial resistance. Therefore, scientists are looking at other strategies.
Cell & Microbiology
Sep 19, 2016
0
18
Every day, we are exposed to millions of harmful bacteria that can cause infectious diseases, such as the E. coli bacteria. Now, researchers at the Institute of Bioengineering and Nanotechnology (IBN) of Agency for Science, ...
Bio & Medicine
Jun 6, 2016
0
40
A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outsmart drug-resistant cancers.
Biochemistry
May 25, 2016
0
100
